The Incidences and Related CT Features of Vascular Lake Phenomenon on Angiography Before Chemoembolization

Purpose To elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis (HMT) on transarterial angiography before chemoembolization, and to identity CT features predictive for it. Materials and Methods A comp...

Full description

Saved in:
Bibliographic Details
Published inCardiovascular and interventional radiology Vol. 47; no. 2; pp. 225 - 233
Main Authors Yang, Kai-Lun, Guo, Ya-Pan, Mao, Xin-Yu, Shen, Jian, Zou, Jian-Wei, Li, Ming-Ming, Li, Zhi
Format Journal Article
LanguageEnglish
Published New York Springer US 01.02.2024
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0174-1551
1432-086X
1432-086X
DOI10.1007/s00270-023-03651-3

Cover

Abstract Purpose To elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis (HMT) on transarterial angiography before chemoembolization, and to identity CT features predictive for it. Materials and Methods A comprehensive evaluation involved 665 subjects for incidence analysis, comprising 527 of HCC, 33 of ICC and 105 of HMT. VLP was characterized as intratumoral contrast material pool persisting late into venous phase. Incidences were cataloged on both super-selective and common hepatic artery angiography. For CT features analysis, a subset of 182 cases were analyzed. Enhancement ratio served as an index for comparative analysis of nodule enhancement degrees. Results In HCC, incidence of VLP ascertained via super-selective angiography was 13.5%, whereas it as 7.8% on common hepatic artery angiography. Remarkably, no incidences of VLP were recorded in either ICC or HMT cases. On pre-interventional CT, the prevalence of pseudocapsule was statistically greater in VLP group than Non-VLP group (66.6% vs. 37.6%, P  = 0.015). The Houndsfield units (HU) of tumors in plain scan ( P  = 0.007), arterial phase ( P  = 0.001), venous phase ( P  = 0.041), arterial phase enhancement ratio ( P  < 0.001) were statistically higher in VLP group compared to Non-VLP group. Arterial phase enhancement ratio ( P  = 0.025), presence of pseudocapsule ( P  = 0.001), HU of tumor in plain scan ( P  = 0.035) serve as independent risk factors for VLP manifestation. Conclusion VLP is a distinct angiography phenomenon uniquely associated with HCC. High arterial phase enhancement ratio, presence of pseudocapsule, high HU of tumor in plain scan are independent risk factors for VLP.
AbstractList To elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis (HMT) on transarterial angiography before chemoembolization, and to identity CT features predictive for it. A comprehensive evaluation involved 665 subjects for incidence analysis, comprising 527 of HCC, 33 of ICC and 105 of HMT. VLP was characterized as intratumoral contrast material pool persisting late into venous phase. Incidences were cataloged on both super-selective and common hepatic artery angiography. For CT features analysis, a subset of 182 cases were analyzed. Enhancement ratio served as an index for comparative analysis of nodule enhancement degrees. In HCC, incidence of VLP ascertained via super-selective angiography was 13.5%, whereas it as 7.8% on common hepatic artery angiography. Remarkably, no incidences of VLP were recorded in either ICC or HMT cases. On pre-interventional CT, the prevalence of pseudocapsule was statistically greater in VLP group than Non-VLP group (66.6% vs. 37.6%, P = 0.015). The Houndsfield units (HU) of tumors in plain scan (P = 0.007), arterial phase (P = 0.001), venous phase (P = 0.041), arterial phase enhancement ratio (P < 0.001) were statistically higher in VLP group compared to Non-VLP group. Arterial phase enhancement ratio (P = 0.025), presence of pseudocapsule (P = 0.001), HU of tumor in plain scan (P = 0.035) serve as independent risk factors for VLP manifestation. VLP is a distinct angiography phenomenon uniquely associated with HCC. High arterial phase enhancement ratio, presence of pseudocapsule, high HU of tumor in plain scan are independent risk factors for VLP.
To elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis (HMT) on transarterial angiography before chemoembolization, and to identity CT features predictive for it.PURPOSETo elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis (HMT) on transarterial angiography before chemoembolization, and to identity CT features predictive for it.A comprehensive evaluation involved 665 subjects for incidence analysis, comprising 527 of HCC, 33 of ICC and 105 of HMT. VLP was characterized as intratumoral contrast material pool persisting late into venous phase. Incidences were cataloged on both super-selective and common hepatic artery angiography. For CT features analysis, a subset of 182 cases were analyzed. Enhancement ratio served as an index for comparative analysis of nodule enhancement degrees.MATERIALS AND METHODSA comprehensive evaluation involved 665 subjects for incidence analysis, comprising 527 of HCC, 33 of ICC and 105 of HMT. VLP was characterized as intratumoral contrast material pool persisting late into venous phase. Incidences were cataloged on both super-selective and common hepatic artery angiography. For CT features analysis, a subset of 182 cases were analyzed. Enhancement ratio served as an index for comparative analysis of nodule enhancement degrees.In HCC, incidence of VLP ascertained via super-selective angiography was 13.5%, whereas it as 7.8% on common hepatic artery angiography. Remarkably, no incidences of VLP were recorded in either ICC or HMT cases. On pre-interventional CT, the prevalence of pseudocapsule was statistically greater in VLP group than Non-VLP group (66.6% vs. 37.6%, P = 0.015). The Houndsfield units (HU) of tumors in plain scan (P = 0.007), arterial phase (P = 0.001), venous phase (P = 0.041), arterial phase enhancement ratio (P < 0.001) were statistically higher in VLP group compared to Non-VLP group. Arterial phase enhancement ratio (P = 0.025), presence of pseudocapsule (P = 0.001), HU of tumor in plain scan (P = 0.035) serve as independent risk factors for VLP manifestation.RESULTSIn HCC, incidence of VLP ascertained via super-selective angiography was 13.5%, whereas it as 7.8% on common hepatic artery angiography. Remarkably, no incidences of VLP were recorded in either ICC or HMT cases. On pre-interventional CT, the prevalence of pseudocapsule was statistically greater in VLP group than Non-VLP group (66.6% vs. 37.6%, P = 0.015). The Houndsfield units (HU) of tumors in plain scan (P = 0.007), arterial phase (P = 0.001), venous phase (P = 0.041), arterial phase enhancement ratio (P < 0.001) were statistically higher in VLP group compared to Non-VLP group. Arterial phase enhancement ratio (P = 0.025), presence of pseudocapsule (P = 0.001), HU of tumor in plain scan (P = 0.035) serve as independent risk factors for VLP manifestation.VLP is a distinct angiography phenomenon uniquely associated with HCC. High arterial phase enhancement ratio, presence of pseudocapsule, high HU of tumor in plain scan are independent risk factors for VLP.CONCLUSIONVLP is a distinct angiography phenomenon uniquely associated with HCC. High arterial phase enhancement ratio, presence of pseudocapsule, high HU of tumor in plain scan are independent risk factors for VLP.
PurposeTo elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis (HMT) on transarterial angiography before chemoembolization, and to identity CT features predictive for it.Materials and MethodsA comprehensive evaluation involved 665 subjects for incidence analysis, comprising 527 of HCC, 33 of ICC and 105 of HMT. VLP was characterized as intratumoral contrast material pool persisting late into venous phase. Incidences were cataloged on both super-selective and common hepatic artery angiography. For CT features analysis, a subset of 182 cases were analyzed. Enhancement ratio served as an index for comparative analysis of nodule enhancement degrees.ResultsIn HCC, incidence of VLP ascertained via super-selective angiography was 13.5%, whereas it as 7.8% on common hepatic artery angiography. Remarkably, no incidences of VLP were recorded in either ICC or HMT cases. On pre-interventional CT, the prevalence of pseudocapsule was statistically greater in VLP group than Non-VLP group (66.6% vs. 37.6%, P = 0.015). The Houndsfield units (HU) of tumors in plain scan (P = 0.007), arterial phase (P = 0.001), venous phase (P = 0.041), arterial phase enhancement ratio (P < 0.001) were statistically higher in VLP group compared to Non-VLP group. Arterial phase enhancement ratio (P = 0.025), presence of pseudocapsule (P = 0.001), HU of tumor in plain scan (P = 0.035) serve as independent risk factors for VLP manifestation.ConclusionVLP is a distinct angiography phenomenon uniquely associated with HCC. High arterial phase enhancement ratio, presence of pseudocapsule, high HU of tumor in plain scan are independent risk factors for VLP.
Purpose To elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis (HMT) on transarterial angiography before chemoembolization, and to identity CT features predictive for it. Materials and Methods A comprehensive evaluation involved 665 subjects for incidence analysis, comprising 527 of HCC, 33 of ICC and 105 of HMT. VLP was characterized as intratumoral contrast material pool persisting late into venous phase. Incidences were cataloged on both super-selective and common hepatic artery angiography. For CT features analysis, a subset of 182 cases were analyzed. Enhancement ratio served as an index for comparative analysis of nodule enhancement degrees. Results In HCC, incidence of VLP ascertained via super-selective angiography was 13.5%, whereas it as 7.8% on common hepatic artery angiography. Remarkably, no incidences of VLP were recorded in either ICC or HMT cases. On pre-interventional CT, the prevalence of pseudocapsule was statistically greater in VLP group than Non-VLP group (66.6% vs. 37.6%, P  = 0.015). The Houndsfield units (HU) of tumors in plain scan ( P  = 0.007), arterial phase ( P  = 0.001), venous phase ( P  = 0.041), arterial phase enhancement ratio ( P  < 0.001) were statistically higher in VLP group compared to Non-VLP group. Arterial phase enhancement ratio ( P  = 0.025), presence of pseudocapsule ( P  = 0.001), HU of tumor in plain scan ( P  = 0.035) serve as independent risk factors for VLP manifestation. Conclusion VLP is a distinct angiography phenomenon uniquely associated with HCC. High arterial phase enhancement ratio, presence of pseudocapsule, high HU of tumor in plain scan are independent risk factors for VLP.
Author Mao, Xin-Yu
Shen, Jian
Li, Ming-Ming
Zou, Jian-Wei
Li, Zhi
Yang, Kai-Lun
Guo, Ya-Pan
Author_xml – sequence: 1
  givenname: Kai-Lun
  surname: Yang
  fullname: Yang, Kai-Lun
  organization: Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Department of Radiology, Affiliated Lianyungang Hospital of Xuzhou Medical University
– sequence: 2
  givenname: Ya-Pan
  surname: Guo
  fullname: Guo, Ya-Pan
  organization: Department of Interventional Radiology, Suzhou Xiangcheng People’s Hospital
– sequence: 3
  givenname: Xin-Yu
  surname: Mao
  fullname: Mao, Xin-Yu
  organization: Department of Interventional Radiology, The First Affiliated Hospital of Soochow University
– sequence: 4
  givenname: Jian
  surname: Shen
  fullname: Shen, Jian
  organization: Department of Interventional Radiology, The First Affiliated Hospital of Soochow University
– sequence: 5
  givenname: Jian-Wei
  surname: Zou
  fullname: Zou, Jian-Wei
  organization: Department of Interventional Radiology, The First Affiliated Hospital of Soochow University
– sequence: 6
  givenname: Ming-Ming
  surname: Li
  fullname: Li, Ming-Ming
  organization: Department of Interventional Radiology, The First Affiliated Hospital of Soochow University
– sequence: 7
  givenname: Zhi
  orcidid: 0000-0001-7613-4193
  surname: Li
  fullname: Li, Zhi
  email: lizhisoochow@suda.edu.cn
  organization: Department of Interventional Radiology, The First Affiliated Hospital of Soochow University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38273130$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1r3DAQhkVISDZp_0APRdBLL270YVn2MV2aNrDQUralNzHWjna9saWNZB-SXx9lN20hh4CEQDyPNDPvOTn2wSMh7zj7xBnTl4kxoVnBhCyYrBQv5BGZ8VKKgtXVn2MyY1yXBVeKn5HzlLaMcVULdUrOZC205JLNyHa5QXrjbbdCbzFR8Cv6E3sYcUXnS3qNME4x3wdHf0OyUw-RLuAW6Y8N-jDk7WleV37dhXWE3eaefkYXItL5BoeAQxv67gHGLvg35MRBn_Dt83lBfl1_Wc6_FYvvX2_mV4vCSq3GorVNqSootShzL9LJRqNwoBxCpZgG1wjg2GqskWsumqp9alPwGprWWsfkBfl4eHcXw92EaTRDlyz2PXgMUzKiEaIstWQ8ox9eoNswRZ-r21NSiLqpMvX-mZraAVdmF7sB4r35O8UMiANgY0gpovuHcGaeojKHqEyOyuyjMjJL9QvJduN-UGOErn9dlQc15X_8GuP_sl-xHgHbaqZl
CitedBy_id crossref_primary_10_25259_JCIS_66_2024
crossref_primary_10_1016_j_acra_2025_02_020
Cites_doi 10.2147/OTT.S297523
10.1148/radiol.2020191470
10.1007/s00270-017-1678-1
10.1007/s00270-020-02501-w
10.1016/j.phrs.2021.105507
10.3748/wjg.v24.i37.4291
10.2214/AJR.20.24708
10.1007/s00270-010-9975-y
10.1007/s11604-015-0486-2
10.21037/tcr.2020.03.65
10.1148/radiol.2018181494
10.1046/j.1440-1746.2000.02323.x
10.1159/000488035
ContentType Journal Article
Copyright Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2024. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Copyright_xml – notice: Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2024. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
DBID AAYXX
CITATION
NPM
3V.
7RV
7TO
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
H94
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00270-023-03651-3
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Nursing & Allied Health Database (NC LIVE)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central (subscription)
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Oncogenes and Growth Factors Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central (subscription)
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-086X
EndPage 233
ExternalDocumentID 38273130
10_1007_s00270_023_03651_3
Genre Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29B
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
6PF
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFJLC
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGVAE
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
YLTOR
Z45
Z7U
Z7X
Z7Y
Z82
Z87
Z8O
Z8S
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PUEGO
NPM
7TO
7XB
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c375t-bc9456a47241433f397e2fa5fea6507af92a1eb7e8e171296b0174218a9bccf03
IEDL.DBID 7X7
ISSN 0174-1551
1432-086X
IngestDate Fri Sep 05 08:18:54 EDT 2025
Fri Jul 25 09:36:03 EDT 2025
Thu Apr 03 06:56:59 EDT 2025
Wed Oct 01 01:24:04 EDT 2025
Thu Apr 24 23:08:44 EDT 2025
Fri Feb 21 02:40:25 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Pseudocapsule
Enhancement ratio
Vascular lake phenomenon
Incidence
Language English
License 2024. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-bc9456a47241433f397e2fa5fea6507af92a1eb7e8e171296b0174218a9bccf03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7613-4193
PMID 38273130
PQID 2922322896
PQPubID 54058
PageCount 9
ParticipantIDs proquest_miscellaneous_2922447301
proquest_journals_2922322896
pubmed_primary_38273130
crossref_primary_10_1007_s00270_023_03651_3
crossref_citationtrail_10_1007_s00270_023_03651_3
springer_journals_10_1007_s00270_023_03651_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20240200
2024-02-00
2024-Feb
20240201
PublicationDateYYYYMMDD 2024-02-01
PublicationDate_xml – month: 2
  year: 2024
  text: 20240200
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Vienna
PublicationTitle Cardiovascular and interventional radiology
PublicationTitleAbbrev Cardiovasc Intervent Radiol
PublicationTitleAlternate Cardiovasc Intervent Radiol
PublicationYear 2024
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Ishimaru, Morikawa, Sakugawa, Sakamoto, Motoyoshi, Ikebe, Uetani (CR13) 2018; 24
Seki, Hori, Kobayashi, Narumiya (CR4) 2011; 34
Li, Wang, Chen, Li, Kuang, Han, Ren, Duan (CR6) 2021; 14
Kong, Jiang, Zhang, Wang, Li, Shen, Guo, Sun, Chen, Chen, Xu (CR5) 2020; 9
CR8
Cavalcante, Nasser, Motta-Leal-Filho, Affonso, Galastri, De Fina, Garcia, Wolosker (CR2) 2017; 40
Chernyak, Fowler, Kamaya, Kielar, Elsayes, Bashir, Kono, Do, Mitchell, Singal, Tang, Sirlin (CR11) 2018; 289
Hu, Zhong, Zhang, Dai, Li, Shen, Huang, Zhang, Li, Ni (CR7) 2020; 43
Seki, Hori, Shimono (CR1) 2015; 33
Ji, Zhu, Xu, Wang, Wu, Tang, Li, Wang (CR10) 2020; 294
Zheng, Zhang, Wu, Zhang, Wang (CR12) 2021; 166
Yamanaka, Yamanaka, Nakasho, Tanaka, Ando, Yasui, Kuroda, Takata, Maeda, Matsushita, Uematsu, Okamoto (CR3) 2000; 15
Zhang, Sun, Ji, Zhong, Zhou, Song, Hou, Huang, Zhang, Li, Zhu, Ni (CR9) 2021; 217
GW Ji (3651_CR10) 2020; 294
A Seki (3651_CR4) 2011; 34
B Hu (3651_CR7) 2020; 43
A Seki (3651_CR1) 2015; 33
J Yamanaka (3651_CR3) 2000; 15
V Chernyak (3651_CR11) 2018; 289
3651_CR8
N Zheng (3651_CR12) 2021; 166
H Ishimaru (3651_CR13) 2018; 24
H Li (3651_CR6) 2021; 14
RN Cavalcante (3651_CR2) 2017; 40
J Kong (3651_CR5) 2020; 9
L Zhang (3651_CR9) 2021; 217
References_xml – volume: 14
  start-page: 4659
  year: 2021
  end-page: 4670
  ident: CR6
  article-title: Occurrence, related factors and prognostic value of vascular lake in hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S297523
– volume: 294
  start-page: 568
  year: 2020
  end-page: 579
  ident: CR10
  article-title: Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional study
  publication-title: Radiology
  doi: 10.1148/radiol.2020191470
– volume: 40
  start-page: 1044
  year: 2017
  end-page: 1051
  ident: CR2
  article-title: Occurrence of vascular lake phenomenon as a predictor of improved tumor response in HCC patients that underwent DEB-TACE
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s00270-017-1678-1
– volume: 43
  start-page: 1460
  year: 2020
  end-page: 1467
  ident: CR7
  article-title: Occurrence of vascular lake phenomenon before embolization for the prediction of lipiodol uptake for intermediate-stage hepatocellular carcinoma patients that underwent cTACE
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s00270-020-02501-w
– volume: 166
  year: 2021
  ident: CR12
  article-title: Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2021.105507
– volume: 24
  start-page: 4291
  year: 2018
  end-page: 4296
  ident: CR13
  article-title: Cerebral lipiodol embolism related to a vascular lake during chemoembolization in hepatocellular carcinoma: a case report and review of the literature
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v24.i37.4291
– volume: 217
  start-page: 933
  year: 2021
  end-page: 943
  ident: CR9
  article-title: Imaging changes and clinical complications after drug-eluting bead versus conventional transarterial chemoembolization for unresectable hepatocellular carcinoma: multicenter study
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.20.24708
– volume: 34
  start-page: 557
  year: 2011
  end-page: 565
  ident: CR4
  article-title: Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s00270-010-9975-y
– volume: 33
  start-page: 741
  year: 2015
  end-page: 748
  ident: CR1
  article-title: Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres
  publication-title: Jpn J Radiol
  doi: 10.1007/s11604-015-0486-2
– volume: 9
  start-page: 2895
  year: 2020
  end-page: 2903
  ident: CR5
  article-title: Clinical management of vascular lake during transarterial chemoembolization with CalliSpheres drug-eluting beads (DEBs) for the treatment of hepatocellular carcinoma
  publication-title: Transl Cancer Res
  doi: 10.21037/tcr.2020.03.65
– ident: CR8
– volume: 289
  start-page: 816
  year: 2018
  end-page: 830
  ident: CR11
  article-title: Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients
  publication-title: Radiology
  doi: 10.1148/radiol.2018181494
– volume: 15
  start-page: 1192
  year: 2000
  end-page: 1198
  ident: CR3
  article-title: Clinicopathologic analysis of stage II–III hepatocellular carcinoma showing early massive recurrence after liver resection
  publication-title: J Gastroenterol Hepatol
  doi: 10.1046/j.1440-1746.2000.02323.x
– volume: 15
  start-page: 1192
  year: 2000
  ident: 3651_CR3
  publication-title: J Gastroenterol Hepatol
  doi: 10.1046/j.1440-1746.2000.02323.x
– volume: 14
  start-page: 4659
  year: 2021
  ident: 3651_CR6
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S297523
– volume: 9
  start-page: 2895
  year: 2020
  ident: 3651_CR5
  publication-title: Transl Cancer Res
  doi: 10.21037/tcr.2020.03.65
– volume: 33
  start-page: 741
  year: 2015
  ident: 3651_CR1
  publication-title: Jpn J Radiol
  doi: 10.1007/s11604-015-0486-2
– volume: 24
  start-page: 4291
  year: 2018
  ident: 3651_CR13
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v24.i37.4291
– volume: 40
  start-page: 1044
  year: 2017
  ident: 3651_CR2
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s00270-017-1678-1
– volume: 294
  start-page: 568
  year: 2020
  ident: 3651_CR10
  publication-title: Radiology
  doi: 10.1148/radiol.2020191470
– volume: 217
  start-page: 933
  year: 2021
  ident: 3651_CR9
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.20.24708
– volume: 34
  start-page: 557
  year: 2011
  ident: 3651_CR4
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s00270-010-9975-y
– volume: 43
  start-page: 1460
  year: 2020
  ident: 3651_CR7
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s00270-020-02501-w
– volume: 289
  start-page: 816
  year: 2018
  ident: 3651_CR11
  publication-title: Radiology
  doi: 10.1148/radiol.2018181494
– volume: 166
  year: 2021
  ident: 3651_CR12
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2021.105507
– ident: 3651_CR8
  doi: 10.1159/000488035
SSID ssj0015825
Score 2.3927407
Snippet Purpose To elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic...
To elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic metastasis...
PurposeTo elucidate incidence rates of vascular lake phenomenon (VLP) in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), hepatic...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 225
SubjectTerms Angiography
Cardiology
Chemoembolization
Cholangiocarcinoma
Clinical Investigation
Comparative analysis
Hepatic artery
Hepatocellular carcinoma
Imaging
Liver
Liver cancer
Medical imaging
Medicine
Medicine & Public Health
Metastases
Nuclear Medicine
Radiology
Risk factors
Tumors
Ultrasound
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT9wwEB21i1T1Ai2FEgqVK3EDo6ztbJLjFkFRW1APLIJTZDtjKB8JYncv_fUdJ06qAq2ElFscx_bYM280M88AW3kpsgyVT2kUhiuda56p0nGrTKljmWHahGKOjkeHE_X1LDkLRWHTLtu9C0k2mrovdvMeVMzJxnDSusmQy5ewkHgHZQAL4y_n3_b76EGSiTZ1MVXcQ4JQLPN0L38bpEco81GEtDE8B0sw6Ybc5ptc785nZtf-esDm-Nw5vYHFgETZuN06b-EFVsvw6ijE2t_BFe0gRuqjvXV0ynRVsiZ1Dku2d8I8dpyTr85qx05DOiv7rq-R_bjEyvM61BWjZ1xd_Ay02OwzEkRG5kkKarw19U0oAl2BycH-yd4hDzczcCvTZMaNzQl4aZWS_VdSOgI1KJxOHGpCfKl2udBDNClmOEwJUYyMlwWhCZ0ba10sV2FAo8A1YMa6kVDWpEaTs4KYNfw7sdQmFqi0i2DYiaewgbbc355xU_SEy80iFrSIRbOIhYxgu__mriXt-G_rjU7qRTjA00LkhJsEeaOjCD71r-no-XiKrrCet22U8ioygvftbul_JzPChYQPItjpJP-n83-PZf15zT_Aa0Egq80i34DB7H6OmwSSZuZjOBO_AZSgBBM
  priority: 102
  providerName: Springer Nature
Title The Incidences and Related CT Features of Vascular Lake Phenomenon on Angiography Before Chemoembolization
URI https://link.springer.com/article/10.1007/s00270-023-03651-3
https://www.ncbi.nlm.nih.gov/pubmed/38273130
https://www.proquest.com/docview/2922322896
https://www.proquest.com/docview/2922447301
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1432-086X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015825
  issn: 0174-1551
  databaseCode: AFBBN
  dateStart: 19970101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1432-086X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015825
  issn: 0174-1551
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1432-086X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0015825
  issn: 0174-1551
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJiFe0PgOG5OReAOLxHbq5Glqp5YJWDWhFZWnyHYufI1krO3_z9lxM6GJSZH8YCex7uy73_nOdwCvy1oUBSof0igsV6Y0vFB1w52ytUllgTq4Yk7no5OF-rDMl_HAbRXDKrcyMQjqunP-jPydKEmRCTIPRkeXf7ivGuW9q7GExl3YzQiq-FWtl4PBleWF6EMYteIeGsRLM-HqnLfHUk4ai5MMzzMu_1VMN9DmDU9pUECzPXgQkSMb96x-CHewfQT3TqNv_DH8JI4z2u59ldAVM23NQqgb1uz4nHmstyHbmnUN-xLDT9kn8wvZ2XdsfR6GrmX0jNtvP2IaazZBgrTIfFKBDn_b7iJe2nwCi9n0_PiEx0oK3Emdr7l1JQElozTpayVlQyAERWPyBg0hNG2aUpgMrcYCM00IYGQ9zUj7m9I616TyKezQLPA5MOuakVDOamvIuEAsQr6cVBqbClSmSSDbkrFyMc24r3ZxUQ0JkgPpKyJ9FUhfyQTeDO9c9kk2bh19sOVOFTfcqrpeHgm8Grppq3j_h2mx2_RjlPIiLYFnPVeH38mCcBzp8wTebtl8_fH_z-XF7XPZh_uCQFAf5X0AO-urDb4kELO2h2GlHsLueDaZzH37_uvHKbWT6fzsM_UuxPgv5wTv4w
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxJu0BYwEJ7BIbGedHBAqhWpLdysOW7S3YDtjXm1SurtC_Cl-I-O8KlTRW6XckjjWzNjfN5nxDMCzvBRZhiqkNArLlckNz1TpuVO2NLHMUDehmOnBaHyoPszT-Rr86c_ChLTKfk9sNuqyduEf-SuRE5AJcg9Gb05-8tA1KkRX-xYarVns4-9f5LItXu-9I_0-F2L3_WxnzLuuAtxJnS65dTmRBqM0YZeS0hMgo_Am9WiIrWjjc2EStBozTDSh4ciS0SpCQpNb53wsadwrcFXJWIVa_Xo-OHhJmok2ZVIrHqhId0inOaoX_L-YE0Jywow04fJfIDzHbs9FZhvA270FNzumyrZb07oNa1jdgWvTLhZ_F76ThTHaXtqupAtmqpI1qXVYsp0ZC9xyRb48qz371KW7son5gezjV6xC3Ye6YnRtV1--dWWz2VskCo0sFDGo8djWR90h0XtweCkyvg_rNAt8CMw6PxLKWW0NOTOIWVOfJ5bGxgKV8REkvRgL15U1D901joqhIHMj-oJEXzSiL2QEL4Z3TtqiHhc-vdVrp-gW-KI4M8cIng63aWmGeIupsF61zygVttAIHrRaHT4nM-KNxB8ieNmr-Wzw_89l4-K5PIHr49l0Ukz2DvY34YYgAtZmmG_B-vJ0hY-IQC3t48ZqGXy-7GXyF8OxJqM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEO-mFDASnMBqYjvr5IBQaVm19KEeWrS3YCdjoI-k7e4K8df4dYwTJxWq6K1Sbkkca2bs75vMeAbgTV6JLEPlUxqF5crkhmeqcrxUtjKxzFC3oZi9_dHWkfoySScL8Kc_C-PTKvs9sd2oq6b0_8jXRE5AJsg9GK25kBZxsDn-eH7BfQcpH2nt22l0JrKDv3-R-zb9sL1Jun4rxPjz4cYWDx0GeCl1OuO2zIlAGKUJx5SUjsAZhTOpQ0PMRRuXC5Og1ZhhogkZR5YMWBEqmtyWpYsljXsH7mqppE8n05PB2UvSTHTpk1pxT0vCgZ322J73BWNOaMkJP9KEy39B8RrTvRalbcFv_ADuB9bK1jszewgLWD-Cpb0Ql38Mx2RtjLaarkPplJm6Ym2aHVZs45B5njknv541jn0Nqa9s15wgO_iBta8B0dSMrvX6-89QQpt9QqLTyHxBgwbPbHMaDow-gaNbkfFTWKRZ4DIwW7qRUKXV1pBjg5i1tXpiaWwsUBkXQdKLsShDiXPfaeO0GIozt6IvSPRFK_pCRvBueOe8K_Bx49OrvXaKsNinxZVpRvB6uE3L1MdeTI3NvHtGKb-dRvCs0-rwOZkRhyQuEcH7Xs1Xg_9_Lis3z-UVLNECKXa393eewz1BXKxLNl-FxdnlHF8Ql5rZl63RMvh226vkL8P8Kt4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Incidences+and+Related+CT+Features+of+Vascular+Lake+Phenomenon+on+Angiography+Before+Chemoembolization&rft.jtitle=Cardiovascular+and+interventional+radiology&rft.au=Yang%2C+Kai-Lun&rft.au=Guo%2C+Ya-Pan&rft.au=Mao%2C+Xin-Yu&rft.au=Shen%2C+Jian&rft.date=2024-02-01&rft.issn=1432-086X&rft.eissn=1432-086X&rft.volume=47&rft.issue=2&rft.spage=225&rft_id=info:doi/10.1007%2Fs00270-023-03651-3&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0174-1551&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0174-1551&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0174-1551&client=summon